Mitigating Plastic Pollution While Regenerating Our Oceans

It is estimated that more than 75% of the 8.3 billion metric tons of plastic produced over the last 65 years have turned into waste, of which up to 13 million metric tons end up in our oceans every year.

Plastic is one of the most enduring materials created by humans. Unfortunately, it can take hundreds of years to degrade, and even then, it often becomes microplastics – tiny particles that can be ingested by marine animals. These microplastics enter the food chain, leading to disastrous consequences for our planet and its inhabitants.

Improving plastic waste management globally is critical and individuals and organisations can play a part in reducing plastic pollution and regenerating oceans. Researchers are exploring biodegradable plastics and alternative materials to reduce plastic’s impact and there are many alternative solutions available to reduce single-use plastics.

 

What labs are doing to reduce plastic pollution

Labs can be influential advocates and encourage industry-wide shifts toward more sustainable practices. Of course, labs are key players in the research of plastic pollution, analyzing to help organisations develop a better understanding of the scope of plastic waste worldwide and use those insights to create innovative solutions, especially for marine environments.

But there’s also no denying that labs consume vast amounts of single-use plastic items, including pipette tips, tubes, gloves, and reagent bottles. These plastics are essential for maintaining sterile conditions and avoiding contamination, but their disposal contributes significantly to plastic waste. Lab instruments are also made up of plastic parts and do most of us know the process for disposing of those instruments at the end of their life?

What’s exciting to see is the scientific community strongly advocating for change and implementing practices that already have a significant impact such as:

  • Reviewing the materials used in common consumables and opting for products with minimal plastic content or those made from recyclable materials.
  • Incorporating re-using along with recycling and engaging with suppliers to support re-useable product options and recycling programs
  • Designing experiments and workflows with circular economy principles in mind.
  • Setting targets for reducing plastic waste.

 

An example of plastic sustainable solutions

With a focus on forming a biotech company to tackle plastic pollution, ULUU was started in 2020 by Dr Julia Reisser and Michael Kingsbury. They are trying to solve the growing issue of plastic pollution by prototyping alternative materials to market.

ULUU’s PHA product sample

 

“Unlike synthetic plastics, our materials are not produced using petrochemicals derived from fossil fuels. Instead, they are made from sustainable feedstocks with much more sustainable production processes. And, in the end, our products are compostable and marine-biodegradable, so they don’t pose a lasting impact on the environment,” described Dr. Luke Richards, lead scientist at ULUU.

The mission at ULUU is to replace plastics with materials that are good for the world. They’re producing a versatile natural polymer called polyhydroxyalkanoates (PHA), using seaweed as a sustainable resource for that process. The result is a material that is biodegradable and won’t accumulate in oceans and landfills or linger as microplastics in biological systems.

Discover the Challenges in Microplastics Analysis in our webinar >

ULUU scientists Dr Sheik Md Moniruzzaman and Vatsal Meshram in their QC lab using the Agilent 1260 Infinity II LC with Agilent InfinityLab LC/MSD iQ

 

In terms of climate change, using seaweed as a feedstock, ULUU captures carbon dioxide from the atmosphere and converts it into PHA. Their process also doesn’t rely on conventional land-based farming, which can take land away from natural ecosystems. Additionally, farming seaweed has some positive impacts on oceans. Research indicates that seaweed helps clean up environmental pollutants and reverses acidification and eutrophication.

ULUU uses bioreactors ranging from 1 to 50 L to make their products. They also use specialised equipment to investigate injection moulding and turn their PHA product into solid objects for prototyping. The entire production process from seaweed input to the finished PHA powder is monitored by their QC lab, in which most assays use chromatography instruments. These instruments include two Agilent 1260 Infinity II liquid chromatographs (LCs) and one Agilent 8890 gas chromatograph (GC), with detection by an Agilent InfinityLab LC/MSD iQ, an Agilent 1260 Infinity II refractive index detector (RID), and an Agilent 5977B GC/MSD.

Agilent 8890
Agilent LC/MSD iQ
Agilent 1260 Infinity II
Agilent 5977B GC-MSD

 

Sustainability is the way of the future for all laboratories and investing in the right solutions now can turn the tide for the future. Chemetrix is the partner labs that need to reach its sustainability goals and implement solutions that will reduce its environmental impact and plastic waste now and in years to come.

 

Free Your Workflows from Common Time Traps

The smarter way to avoid time traps in your laboratory.

Do you think time-consuming tasks in ICP-MS are inevitable? Something that has to be accepted as part of routine operations? Find out how ICP-MS 7850 helps you easily meet your analytical requirements while simplifying laboratory workflow and improving performance and satisfaction for analysts and laboratory managers.

The intelligence embedded in the ICP-MS 7850 provides a more efficient way to perform metal analysis by reducing unnecessary wasted time so that your staff can focus on activities that generate greater value for the laboratory.

 

What you will learn

  • Simplify the preparation of your samples and standards.
  • Facilitate the implementation of analytical methods and the handling of the instrument.
  • Improve confidence in your results whatever the matrix analysed
  • Maintenance operations and reduce instrument downtime
  • Optimise and obtain better instrument and sample insights

 

Date: Thursday, June 14, 2024
Time: 01:00 PM – 02:00 PM (GMT)
Speaker: Dr. Raimund Wahlen, Product Specialist, Agilent Technologies

 

Register now >

 

5 Tips to Reduce Instrument Downtime

Labs are meant to be shining examples of precision, innovation and efficiency. But, imagine a high-tech instrument, meticulously calibrated, sitting idle, its potential squandered. Meanwhile, researchers wait impatiently, experiments are delayed, and costs mount. Labs cannot thrive when they aren’t operating at the highest level possible.

Unplanned downtime affects your lab’s ability to deliver data quickly and accurately – which can hurt your bottom line. It should be a top priority for every lab to optimise its operations and paying attention to downtime is vital to success. But the good news is: that you can significantly reduce the frequency and impact of downtime.

Watch our webinar on how to Reduce Instrument Downtime With Usage-Based Maintenance webinar >

 

Do preventative maintenance

Scheduling regular preventive maintenance maximises uptime, extends the useful life of your instruments, and increases the accuracy of your results. It can even reduce unexpected repairs by 24%. Check if instruments provide early maintenance warnings and follow them closely. If not, create a schedule for instrument maintenance that all staff must follow. Lab software can also send alerts for preventative maintenance. It’s also advised to run analysis or diagnostics on instruments to see if they are operating efficiently.

 

Increase users’ knowledge and skills

When staff are empowered with access to learning and troubleshooting resources, it can improve lab throughput and analytical accuracy. Chemetrix provides many troubleshooting resources so staff can respond to minor instrument challenges first. As additional support, Chemetrix Academy provides training resources, tips and tricks to make the most of instruments and methods, thereby reducing instrument downtime.

Download our poster on GC/MS Best Practices >

 

Optimise methods

Ready-to-go methods for regulated and routine analyses, plus prewritten standard operating procedures can save weeks of method development and documentation time plus reduce instrument downtime. A robust method also reduces the risk of unexpected downtime due to unreliable results. Additionally, instruments and software that provide the option of automation for certain tasks reduce human error.

Download our poster on How to Optimise Your ICP-OES Methods >

 

Check lab data

An analysis of instrument data can provide insights such as when and where downtime issues are prevalent. By using the instrument data available, it is far easier to an overall picture of the lab’s downtime incidents and identify solutions for specific challenges. If a lab doesn’t yet have a robust software solution implemented, doing so may save time and money as it can analyse instrument performance, including downtime, and monitor overall performance for improved operational efficiency.

Agilent Cary 3500 UV-Vis

 

Plan upgrades based on equipment lifespan

Instruments have a finite lifespan. It’s essential to know when equipment was purchased or installed and also regularly assess its age and performance. Use historical data to predict when an instrument might fail. Predictive maintenance involves analysing patterns and identifying early warning signs. It’s vital for labs to plan for upgrades or replacements before critical failures occur. This proactive approach minimises unplanned downtime. Remember, treating instruments as long-term investments rather than disposable tools pays off in the long run.

Customers expect reliable and timely services from labs. When the integrity and quality of the results or the timely delivery of analysis is compromised, labs may find that their reputation and customer trust are compromised leading to poor business outcomes. Instrument downtime is in fact easily addressed if staff and management work together with a holistic approach. By working with Chemetrix, labs can be supported with the resources they need to enjoy a great return on investment from their instruments.

Watch our webinar on how to Free Your Workflows from Common Time Traps >

Agilent 7850 ICP-MS

 

Having the best instruments is just one factor of lab success, using them well is the other. As the scientific landscape continues to surprise with discoveries and developments, it is possible to adapt methods and instrument functions to remain abreast of industry trends or client requirements. Chat with our team to find out how we can provide the instruments you need along with our renowned after-sales support to help your lab achieve its goals.

 

A Look at Data Integrity in Pharma Labs

Data integrity problems in pharmaceutical quality control laboratories are driving more regulatory action than ever before. What has changed to drive all this activity? While plenty of information is available, much of it seems to confuse rather than clarify.

Data integrity is a critical aspect in pharmaceutical laboratories, ensuring that the data generated during business operations and drug manufacturing is accurate, complete, and reliable. When data is reliable, business owners can make informed decisions, improve product quality, and contribute to overall success.

Data integrity is important because it builds trust with stakeholders and ensures that the information used to evaluate drug safety, efficacy, and quality is trustworthy. For patients using a pharmaceutical product, it assures them of the safety that is promised and provides qualitative evidence to support the manufacturer’s guarantee.

As W.E. Deming said,

“Without data, you are just another person with an opinion.”

Let’s explore some common myths of data integrity by looking at facts, based on a study of available resources and direct interactions with U.S. Food and Drug Administration (FDA) staff and their consultants.

 

Myth: All this regulation around data integrity is new

Data integrity has been a concern for decades. The FDA’s focus on it began with 21 CFR Part 11 in 1998. In 2003, after the pharmaceutical industry spent years struggling with the regulation, the FDA released its Scope and Application guidance, clarifying some of the requirements in Part 11. This guidance also included a discussion of the FDA’s selective enforcement strategy based on what the administration was finding during its inspections. In 2010, the FDA announced its focus on data integrity inspections. At that time, however, few people within the FDA were qualified to understand the data integrity aspects of computerised systems. Thus, beginning in 2013, data integrity has been a primary inspection point, and there has been a visible increase in data integrity enforcement across all geographies. In addition, starting in 2014, as a result of those inspections, the FDA has often included the names of hardware and software products in their warning letters and related public information documents in a less than subtle message to the hardware and software makers that the administration expects them to assist customers with data integrity and compliance concerns.

 

Myth: Data integrity is an IT issue

Success in addressing data integrity relies less on technology and more on fostering a culture, organisation, and mindset conducive to excellence. Key contributors to effective data integrity solutions include a shared vision of data integrity practices and a commitment to continuous improvement. In both paper-based and electronic systems, data integrity issues can arise, each presenting unique challenges and requiring tailored remediation strategies. Many responses to these issues overlook the possibility of such occurrences in paper-based systems, failing to conduct risk assessments or identify areas for remediation. Compliance and best practices must span data generation, transformation, maintenance, accuracy, and consistency. Cultivating the right culture, assembling capable teams, ensuring transparency in data integrity performance, and aligning company goals with data integrity objectives are all essential components of a successful data integrity initiative.

 

Myth: Only the software needs to be compliant

Software often does not comply with regulations. The software itself is inert; software contains the technical controls to support compliance with the applicable regulations. In addition to technical controls, procedural controls must also be in place. A discussion about procedural controls versus technical controls is often seen in FDA warning letters, particularly when gaps in a system’s ability to support technical controls required by various regulations have been exploited.

A standard operating procedure (SOP), used as a procedural control, can substitute for a technical control as long as:

• People are trained on that SOP

• The SOP is followed

• Adherence to the SOP is confirmed by quality oversight and/or compliance auditing

Often, however, even if SOPs exist, they are not followed, and adherence isn’t properly verified. Consequently, the FDA will demand system remediation to prevent a recurrence of the behaviour. Audit trails within computerised systems are an example of technical controls. The software must be able to generate audit trails that contain all the components the regulations require, and then those controls must be enabled.

Analytical instrument manufacturers are taking compliance and regulations into account with their products. As an example, Agilent is applying critical thinking to redesigning laboratory software to help respond to new regulatory compliance realities. Many systems may generate audit trail reports in printed form, but the new version of the Agilent OpenLAB Chromatography Data System has a built-in tool that allows a user to electronically review electronic audit trails entries. These audit trail entries are organised by type, an online review can be performed, and electronic signatures incorporated.

Chromatography Data Systems
Chromatography Data Systems

 

If data integrity regulation compliance is a necessity for your pharma lab, Chemetrix is able to provide solutions that include instruments and software that can help ensure your data is not only well managed and organised, but kept safe and generated with adherence to all the regulatory guidelines.

Data integrity problems can severely impact business operations, leading to financial losses, legal issues, and damaged reputation. It forms the foundation of for reliable pharmaceutical research, development, and manufacturing and, therefore, should be as error-free and precise as possible. It goes beyond being just a practice; data integrity is the cornerstone of trust and excellence in pharmaceutical labs, paving the way for groundbreaking discoveries and lifesaving innovations.

 

Agilent BioTek 406 FX Microplate Washer Dispenser: Technology-Driven Application Diversity and Workflow Efficiency

Introducing Agilent BioTek’s new 406 FX microplate washer dispenser. Built on decades of innovation and success, the 406 FX is the latest advancement in microplate washing and dispensing. The 406 FX integrates parallel peristaltic and syringe pump dispensing with microplate assay washing within a singular platform. The compact design of the 406 FX delivers fast, full-plate washing along with six reagent dispensers. From basic ELISA, to sensitive cell washing, to biomagnetic bead washing, the 406 FX offers modules to address a myriad of assay requirements and workflows.

The automated microplate dispensers perform across a range of volumes offering simple, repeatable, and precise liquid delivery. Modular peristaltic and syringe pump dispensers help to meet varied liquid handling requirements, catering to the broadest spectrum of assay workflow requirements. This multidisciplinary tool enables researchers to drive a diverse spectrum of applications while maintaining workflow efficiency.

 

Speaker

Dr. Charles William Amirmansour
Global Business Development Manager
Agilent Technologies, Inc.

Dr. Amirmansour is a Global Business Development Manager (Cell Analysis Division at Agilent BioTek) who offers a unique set of skills, creating cutting-edge business development programs, with an extensive background across the Life Science and Drug Discovery domain. Additionally, his strong academic and industry experience resonates with research-based microplate and assay technologies. His academic career started when he received his undergraduate degree at King’s College London (University of London) whilst gaining research experience at The William Harvey Research Institute (Queen Mary University of London) under the supervision of Nobel Laurate, Prof. Sir. John Vane. He then obtained his doctorate in Clinical Pharmacology from University College London (under the joint supervision of Prof. Sir Patrick Vallance and Prof. Sir Salvador Moncada). Finally, Dr. Amirmansour held two Post-Doctoral positions at The National Heart & Lung Institute and Harefield Heart Science Centre (Imperial College London), respectively under the supervision of world-renowned pioneering cardiothoracic surgeon and Lister Medal awardee, Prof. Sir Magdy Yacoub.

 

Register now >

 

A Compelling Look at Liquid Handling for Microplate Assays

Microplate assays play a crucial role in scientific research and diagnostics. By allowing researchers to perform high-throughput screenings efficiently, the method becomes essential for large-scale experiments, such as drug discovery, where thousands of compounds need to be tested rapidly.

In many microplate-based assays, there is a crucial wash step that plays a significant role in sample preparation and data accuracy.

During the wash step, the fluid (such as reagents, buffers, or unwanted substances) in the microplate well needs to be removed. This process is called aspiration. After aspiration, the microplate well is emptied of the original fluid. Now, it’s time to add a replacement fluid (e.g., a fresh buffer, a specific reagent, or a washing solution). The process of adding the replacement fluid is called dispensing.

The aspiration and dispense steps are critical for maintaining the integrity of microplate-based assays, ensuring accurate results, and optimising workflow efficiency. These labour-intensive procedures can be efficiently automated using instruments that can both wash and dispense reagents on a single hardware platform.

Complete removal or replacement of the original fluid often requires multiple iterations or cycles of aspiration and dispense. After the final aspiration of a wash protocol is completed, often the next step in the assay protocol is the addition of a specific reagent

For example, ELISA reactions are antibody-based reactions that use a series of binding reactions to quantify specific analytes. With a typical ELISA protocol, repeated cycles of microplate washing, reagent addition, and incubation are executed to add specific reagents and to remove unbound material before data collection. When performed manually, this process requires a technician to manage the timing and be available to move plates between the washer and multiple dispensers.

 

What is needed is the utility of an instrument with both washing and dispensing capabilities within the context of widely used applications.

 

The Agilent BioTek 406 FX is a modular system and is fully programmable from either its built-in touch screen or using Agilent BioTek Liquid Handling Control (LHC) software on an attached PC. The 406 FX is an automated microplate processor that can perform microplate washing steps in 96-, 384-, and 1536-well microplates. In addition to standard wash routines, the 406 FX has built-in cell-washing capabilities. An internal buffer-switching valve allows for the selection of up to four different wash buffers without changing bottles. A built-in sonicator provides the capability for automated cleaning maintenance of the dispense manifold.

Agilent BioTek 406 FX Washer Dispenser

 

There are compelling reasons for wanting to make use of a single instrument for these functions. Having both functions in one instrument reduces the need for manual intervention and minimises the time spent switching between different devices. This can improve workflow which then also improves efficiency. A single instrument saves space and is often more cost-effective than buying separate washers and dispensers. Finally, integrated liquid handlers ensure consistent aspiration and dispensing techniques across all wells. This consistency improves data quality and reduces variability.

The advantages of an instrument like Agilent BioTek 406 FX create opportunities for labs to not only improve their operations, it also allow them to offer high-quality analysis output, greater accuracy, and cost-effectiveness. Chemetrix is able to work with your lab to determine the best solution for your needs and ensure that your liquid handling requirements are fulfilled. Speak to one of our consultants today.

 

Ensuring the Sweet Integrity of Honey Quality with Randox Food Testing Solutions

Honey is a beloved golden elixir that is seeing a growing demand worldwide. As one of nature’s food wonders, this natural sweetener is big business and the international trade of honey is worth over 2 billion dollars.

Its sweet taste and myriad of health benefits mean honey holds a special place in the hearts of consumers worldwide. However, the rise in demand for this natural sweetener has led to increased instances of adulteration, where inferior or artificial substances are added to bulk up volumes or enhance appearance. The need for robust quality assurance measures has never been greater if we want to ensure the integrity of the honey industry and maintain the delicate symbiotic relationship between humans and the honey bee.

 

Honey That’s Not Quite Honey

Adulteration in honey refers to the deliberate addition of substances, such as sugar syrups or other sweeteners, to honey with the intent to deceive or manipulate its quality, composition, or appearance. This practice is often carried out to increase profits by diluting pure honey with cheaper ingredients or enhancing its colour and texture to mimic higher-quality varieties.

Adulteration can compromise the authenticity, nutritional value, and sensory attributes of honey, posing risks to consumer health and safety. Detection and prevention of adulteration are essential to maintain the integrity and reputation of honey products in the marketplace.

With a commitment to innovation, integrity, and customer satisfaction, Randox empowers producers to uphold the highest standards of purity and authenticity in their honey products, ensuring consumer trust and market success.

For producers looking to export their honey with confidence, there are solutions available for safeguarding the purity and integrity of this cherished commodity every step of the way.

 

Keeping Honey Bees Healthy

An important pillar of honey quality control is the utilisation of exposomics, a holistic framework that examines the impact of environmental exposures on human health. Exposomics is the study of the comprehensive set of environmental exposures and stressors that impact the well-being and resilience of honey bee colonies.

This approach encompasses various factors, including pesticides, pathogens, pollutants, climate change, habitat loss, and nutritional stressors, among others. By examining the complex interactions between honey bees and their environment, exposomics aims to understand the cumulative effects of these exposures on bee health, colony dynamics, and population decline. Through advanced analytical techniques and interdisciplinary research, exposomics offers insights into strategies for mitigating stressors and promoting the resilience of honey bee populations in the face of environmental challenges.

Watch our webinar on Using Exposomics to Improve Honey Bee Health here >

 

Championing Honey Integrity

As a brand that cares about global honey quality, Randox Food Testing is a beacon of reliability and excellence, offering comprehensive testing solutions and unparalleled expertise to honey producers worldwide. Leveraging cutting-edge technologies and innovative solutions, Randox offers solutions designed to detect and prevent adulteration, ensuring the purity and authenticity of honey products.

Chemetrix equips food producers with the tools they need to safeguard their honey supply chain from farm to fork. Through advanced techniques such as the Randox Biochip Array technology through to our LC-TOF MS from Agilent Technologies, we enable producers to achieve unparalleled levels of traceability and transparency, instilling confidence in consumers and regulatory authorities alike.

This trusted name in analytical instruments understands the need for honey to remain as close to an all-natural product as possible without drug residues and other contaminants affecting its quality. That’s why their products are ideal for honey testing including antibiotics, pesticides and a range of quality tests such as sucrose, glucose/fructose, HMF and Diastase. Biochip Array Technology is ideal for the screening of multiple antimicrobials within honey, up to 54 samples in just 2 hours 30 minutes.

We also offer a variety of TOF LC/MS instruments like the Agilent 6230B TOF LC/MS. Contact one of our consultants for more information.

 

Empowering Honey Producers

There are lots of resources and educational opportunities for honey producers looking to enhance their understanding of quality assurance practices. Randox has webinars, seminars, and educational materials that offer insights into emerging trends, regulatory updates, and best practices in honey production and testing.

 

As a supplier of Randox instruments and products on the African continent, Chemetrix serves as a conduit to ensure honey producers have access to the best testing and analysis solutions available. We are committed to safeguarding the purity and integrity of this cherished commodity every step of the way and helping honey producers guarantee the quality of their products. With some of the world’s best lab equipment available, we can all be part of a culture of continuous improvement and innovation, driving excellence in honey quality control across the industry.

 

Ensuring the Sweet Integrity of Honey Quality

Honey is a beloved golden elixir that is seeing a growing demand worldwide. As one of nature’s food wonders, this natural sweetener is big business and the international trade of honey is worth over 2 billion dollars.

Its sweet taste and myriad of health benefits mean honey holds a special place in the hearts of consumers worldwide. However, the rise in demand for this natural sweetener has led to increased instances of adulteration, where inferior or artificial substances are added to bulk up volumes or enhance appearance. The need for robust quality assurance measures has never been greater if we want to ensure the integrity of the honey industry and maintain the delicate symbiotic relationship between humans and the honey bee.

 

Speaker

Dr. Liberty Sibanda
RandoxFood Diagnostics

 

Watch now >

 

Speakers

Dr. Christopher Mayack
Swarthmore College, Department of Biology


Dr. Robert L. Broadup

Haverford College, Department of Chemistry

 

Register now >

 

Best of Imaging Applications

Cell culture lies at the heart of many biological studies, serving as a foundational technique for a myriad of applications, from basic research to drug discovery. Register for this exciting webinar that will explore the newest features and instrument capabilities supporting kinetic live-cell imaging, from real-time analysis of rapid GPCR signalling pathways to long-term treatment-induced effects on cell proliferation and viability.

 

Speaker

Joe Clayton, PhD
Scientific Program Manager,
Agilent Cell Analysis

 

Register now >

 

Unlocking the Potential of Automated Imaging Tools in Cell Culture and Assay Development

In the dynamic landscape of cell biology research, advancements in technology continually reshape our understanding of cellular processes and pave the way for innovative discoveries. Automated imaging tools stand at the forefront of this revolution, offering researchers valuable insights into improving routine cell culturing techniques and enhancing the effectiveness and reproducibility of downstream cell-based assays.

Automated imaging tools help researchers learn more about how to make cell culturing better and how to improve the accuracy and consistency of cell-based tests. Unlike traditional manual methods, which are prone to subjectivity and variability, automated imaging offers an objective, quantitative analysis of cellular parameters in real time.

This level of precision and consistency is essential for optimising cell culture conditions, evaluating the efficacy of experimental treatments, and ensuring the reproducibility of results across experiments. Additionally, high-content imaging capabilities enable researchers to multiplex their analyses, simultaneously probing multiple cellular features within the same sample. This holistic approach not only enhances the efficiency of assay development but also allows for a more comprehensive assessment of cellular responses to various stimuli.

Overall, automated imaging tools empower researchers to unravel the complexities of cellular processes with unprecedented accuracy and throughput, driving innovation and accelerating discoveries in cell biology.

 

Enhancing Cell Culturing Techniques with Automated Imaging

Cell culture lies at the heart of many biological studies, serving as a foundational technique for a myriad of applications, from basic research to drug discovery. However, traditional methods of assessing cell health and behaviour often rely on subjective observations and manual interventions, leading to variability and inefficiencies. Enter BioTek’s LionHeart FX, which can revolutionise cell culture workflows by providing real-time, quantitative data on cell morphology, viability, and proliferation. BioTek Lionheart FX allows you to capture, process, analyse, annotate images, and produce videos with ease. By automating image acquisition and analysis, researchers can gain deeper insights into cellular dynamics, optimise culture conditions, and ensure reproducibility across experiments.

Agilent BioTek Lionheart FX Automated Microscope

 

Empowering Assay Development

The effectiveness of cell-based assays hinges on the accuracy and reliability of the data obtained. BioTek’s Cytation emerges as a game-changer, offering high-content imaging capabilities that enable multiplexed analysis of cellular parameters in a single experiment. Digital microscopy and multimode detection deliver both phenotypic data and quantitative data from one instrument, maximising laboratory productivity. With its automated imaging and image analysis features, Cytation streamlines assay development accelerates screening processes and enhances the robustness of downstream assays, ultimately driving efficiency and productivity in research endeavours.

Agilent BioTek Cytation C10 Confocal Imaging Reader

 

Optimising Workflow Efficiency with Integrated Liquid Handling

Liquid handling is a critical aspect of cell culture and assay development, where precision and accuracy are paramount. Manual pipetting procedures not only pose a risk of human error but also limit throughput and scalability. In this regard, BioTek’s MultiFlo FX delivers unparalleled flexibility and efficiency by integrating automated liquid handling with imaging capabilities. Whether dispensing media, performing cell-based assays, or conducting plate washing steps, MultiFlo FX streamlines workflows, minimises hands-on time, and ensures consistent results, empowering researchers to focus on data analysis and interpretation.

Agilent BioTek MultiFlo FX Multimode Dispenser

 

Embracing the Future of Cell Biology with BioTek

In the rapidly evolving field of cell biology, leveraging state-of-the-art technology is essential for driving innovation and pushing the boundaries of scientific discovery.

 

BioTek’s Cell Analysis instruments represent a beacon of innovation, offering researchers a comprehensive suite of tools to elevate their research to new heights.